Glucose Transporters in Brain: In Health and in Alzheimer’s Disease
The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Neurons need a continuous supply of glucose, the major source of energy for mammalian brain metabolism. The central nervous system is protected by three main physiological cell barriers. Cell membranes are impermeable for glucose, therefore glucose is transferred across the cell membranes by specific transport proteins: sodium-independent glucose transporters (GLUTs), encoded by SLC2 genes, and sodium-dependent glucose transporters (for example SGLTs), encoded by SLC5 genes. Human brain expresses 10 GLUT proteins and 10 proteins encoded by SLC5 genes. In patients with brain diseases, particularly Alzheimer's (AD) and Huntington's diseases, abnormalities in neuronal glucose metabolism have been showed. The levels of GLUT1 and GLUT3, the major brain glucose transporters, are decreased, especially in the cerebral cortex. Therefore, in AD, hypometabolism of glucose and deficits in energy are observed. Production of ATP from glucose metabolism in sporadic AD declines to 50% and the tendency to decline continues throughout the progression of the disease. This decrease is correlated with O-GlcAcetylation and tau hyperphosphorylation, as the compensatory mechanisms in AD are the utilization of endogenous brain substances and drastic increase in GLUT2 levels. The present review focuses on the changes in the expression of glucose transporters due to AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“researchers asserted that besides its role in glucose reabsorption, SGLT may exhibit other distinct functions in CNS.13–15”
From Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice (2020) · cites this paper as [13]
Citations
Cites
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · cited 2×
“Therefore, the concept of AD was proposed as “type 3 diabetes” [124].”
The SLC2 (GLUT) family of membrane transporters
Mueckler, M., & Thorens, B. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.001 · Cited by 1,328
Craft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166 · cited 1×
“A (cid:2) 40 and A (cid:2) 42 are generated by the proteolytic cleavage of A (cid:2) PP with (cid:2) - and (cid:4) -secretases [132].”
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Insulin receptors are widely distributed in the central nervous system of the rat
HAVRANKOVA, J., ROTH, J., & BROWNSTEIN, M. (1978) · Nature · doi:10.1038/272827a0 · Cited by 1,111
De Vivo, D. C., Trifiletti, R. R., Jacobson, R. I., Ronen, G. M., Behmand, R. A., & Harik, S. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251006 · Cited by 800
Research works printed but not linked: 2
- Welcome, 2011, Long-term disorders of cognitive functions in sober people who episodically use alcohol, role of functional hypoglycemia and insufficiency of gluconeogenesis, Vestnik Smolensk Med Acad, 3, 2
- Welcome, 2013, State of cognitive functions of student-medics with different relationship to alcohol use, 5
Cited by
Items 101–200 of 219
Rasmussen, C. L. M., Hede, E., Routhe, L. G., Körbelin, J., Helgudóttir, S. S., Thomsen, L. B., Schwaninger, M., Burkhart, A., & Moos, T. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15621 · Cited by 20
“…to enable protein secretion, could be to modify the endogenous expression of BECs proteins, for example, nutrient transporters, which may have relevance to aid nutrient supply to the pathological brain (Erickson & Banks, 2013; Garwood et al., 2017; Mezzaroba et al., 2019; Szablewski, 2017).”
BackgroundHuman Glucose Transporters in Health and Selected Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157392 · Cited by 21
Self-citationNesci, V., Russo, E., Arcidiacono, B., Citraro, R., Tallarico, M., Constanti, A., Brunetti, A., Sarro, G. D., & Leo, A. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02062-6 · Cited by 20
Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development
Cacabelos, R., Naidoo, V., Martínez-Iglesias, O. A., Corzo, L., Cacabelos, N., Pego, R., & Carril, J. C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2573-6_13 · Cited by 19
Ramírez-Expósito, M. J., Martínez-Martos, J. M., Cantón-Habas, V., & Carrera-González, M. P. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201111103024 · Cited by 19
“Normal glucose metabolism is crucial in improving and maintaining learning and memory [35-37], and the reduction of brain glucose metabolism caused the cognitive deficits [15, 38, 39].”
BackgroundInfluentialDynamic glucose uptake, storage, and release by human microvascular endothelial cells
Yazdani, S., Bilan, P. J., Jaldín‐Fincati, J. R., Pang, J., Ceban, F., Saran, E., Brumell, J. H., Freeman, S. A., & Klip, A. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-04-0146 · Cited by 18
Jin, L., Pan, Y., Tran, N. L. L., Polychronopoulos, L. N., Warrier, A., Brouwer, K. L. R., & Nicolazzo, J. A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01227 · Cited by 17
Takeuchi, Y., Okinaka, Y., Ogawa, Y., Kikuchi‐Taura, A., Kataoka, Y., Gul, S., Claussen, C., Boltze, J., & Taguchi, A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00170 · Cited by 18
“Glucose is the major energy source for cerebral metabolism, and reduction in its transport had been shown in Alzheimer’s disease (Keaney and Campbell, 2015; Szablewski, 2017; Vallée et al., 2018).”
BackgroundDependence of glucose transport on autophagy and GAPDH activity
Craven, R. J., Frazier, H. N., & Thibault, O. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147747 · Cited by 16
Age-related pathophysiological alterations in molecular stress markers and key modulators of hypoxia
Pinky, P., Neha, N., Salman, M., Kumar, P., Khan, M. A., Jamal, A., & Parvez, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102022 · Cited by 16
Holahan, M. R., Tzakis, N., & Oliveira, F. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00253 · Cited by 17
“Dysfunction of glucose metabolism may be a confluent point in several brain diseases (Pratt et al., 2008; Nijland et al., 2014, 2015; Dean et al., 2016; Anandhan et al., 2017; Lauretti et al., 2017; Szablewski, 2017).”
BackgroundLithium Enhances Hippocampal Glucose Metabolism in an In Vitro Mice Model of Alzheimer’s Disease
Gherardelli, C., Cisternas, P., & Inestrosa, N. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158733 · Cited by 16
“We found no differences in mRNA expression of Glut1, which mediates the transport of glucose into endothelial cells of the blood-brain barrier (Figure 4C) [35,36].”
BackgroundFakorede, S., Sodiq, T. A., Ajagbe͓, A. O., Adeleke, A. J., Edafetanure-Ibeh, O. M., Awobona, T. A., & Aborode, A. T. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251377793 · Cited by 190
“16,47 The number of GLUT1 transporters at the BBB correlates directly with glucose uptake into the brain.”
Li, X., Yang, M., Wang, T., Liu, S., Han, H., & Dong, P. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01753-0 · Cited by 14
“In AD patients, the expression of GLUT-1 and GLUT-3 is significantly diminished, especially within the cerebral cortex (Szablewski 2017).”
Interlinking diabetes and Alzheimer's disease: A pathway through medicinal plant-based treatments
Pattanaik, S. K., Anil, P. M., Jena, S., & Rath, D. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120092 · Cited by 14
Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer’s Disease
Gherardelli, C., Cisternas, P., Vera-Salazar, R. F., Méndez‐Orellana, C., & Inestrosa, N. C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215273 · Cited by 14
Mana, L., Feng, H., Dong, Y., Wang, Y., Shi, J., Tian, J., & Wang, P. (2019) · International Journal of Immunopathology and Pharmacology · doi:10.1177/2058738419841482 · Cited by 14
Wang, L., Curran, G. L., Zhong, R., Xue, Z., Veerareddy, V., Thieschafer, J. S., Min, H.-K. P., Li, L., Lowe, V. J., & Kandimalla, K. K. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251332493 · Cited by 14
Restoring glucose metabolism in Alzheimer's disease by targeting integrated stress response
Sun, H., Guo, S., Jin, H., Ding, L., Chen, Y., Zhang, Y., He, K., Huang, Q., Gu, J., Chen, S., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00618 · Cited by 13
“Research suggests that the reduction in GLUT1 and GLUT3 expression leads to decreased D -glucose levels in neurons, represents an early pathology and contributes to the pathogenesis of AD [14,16].”
Near-Infrared Optical Transducer for Dynamic Imaging of Cerebrospinal Fluid Glucose in Brain Tumor
Liu, S. M., Liu, Y., Zhang, Z., Wang, X., Yang, Y., Sun, K., Yu, J., Chiu, D. T., & Wu, C. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02600 · Cited by 13
Chandan, G., Ganguly, U., Pal, S., Singh, S., Saini, R. V., Chakrabarti, S. S., Saini, A. K., & Chakrabarti, S. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00466-4 · Cited by 13
“Though the results of GLUT inhibition in a neuroblastoma cell line cannot be directly extrapolated to the pathogenesis of AD, it is important to remember that a decreased cerebral glycolytic flux and diminished levels of GLUT3 and GLUT1 are key features of AD pathology [5, 6].”
BackgroundLiu, Y., Dong, Y., Cao, Z., Ji, Y., Cheng, X., & Zheng, X. (2025) · Nutrients · doi:10.3390/nu17213451 · Cited by 12
“Decreased GLUT4 expression and impaired insulin signaling have been observed in the brains of postmortem AD patients [88,89].”
Rosemary extract increases neuronal cell glucose uptake and activates AMPK
Baron, D. C., Marko, D. M., Tsiani, E., & MacPherson, R. E. K. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0014 · Cited by 12
“One of the characteristics of this disease is reduced brain 67 glucose uptake that has been associated with decreased expressions of GLUT1, GLUT3, as well 68 as brain insulin resistance (Ferreira et al. 2018; Simpson et al. 1994; Szablewski 2017).”
BackgroundGlucose Metabolic Abnormality: A Crosstalk between Depression and Alzheimer’s Disease
Yang, S., Li, Y., Tang, Q., Zhang, Y., & Shao, T. (2024) · Current Neuropharmacology · doi:10.2174/011570159x343281240912190309 · Cited by 12
“Research has demonstrated that alterations in the expression and function of these transporters may affect glucose uptake and metabolism in the brain, further exacerbating the energy deficits observed in AD [109].”
Chen, H., Cao, J., Cai, Y., Du, H.-L., Xi, X.-X., Sun, J., Yin, J., Gao, L., & Jing, Y. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113490 · Cited by 13
Onyema, H. N., Berger, M., Musyanovych, A., Bantz, C., Maskos, M., & Freese, C. (2021) · Biointerphases · doi:10.1116/6.0000889 · Cited by 13
Eldridge, R. C., Uppal, K., Shokouhi, M., Smith, M. R., Hu, X. Y., Qin, Z. S., Jones, D. P., & Hajjar, I. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.796067 · Cited by 13
“Given that metabolic dysfunction in the brain and surrounding tissues plays a significant role in the onset and progression of cognitive impairment (de la Monte and Tong, 2014; Campos-Peña et al., 2017; Szablewski, 2017), untargeted metabolomics is primed to make key discoveries about the pathological mechanisms under…”
BackgroundSong, M., & Fan, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098398 · Cited by 11
Rock inhibitors in Alzheimer’s disease
Zheng, C., Xia, W., & Zhang, J. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1547883 · Cited by 12
“Metabolic dysregulation is a signi fi cant feature of AD (Author Anonymous, 2020; Austad et al., 2021), and decreased glucose metabolism occurs in AD brains (Holscher, 2011; Szablewski, 2017; Goedert and Spillantini, 2006).”
Metabolism of Mannose in Cultured Primary Rat Neurons
Rastedt, W., Blumrich, E., & Dringen, R. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2241-9 · Cited by 11
Mei, T., Wang, Z., Wu, J., Liu, X., Tao, W., Wang, S., & Chen, F. (2020) · BioMed Research International · doi:10.1155/2020/1682352 · Cited by 11
Zaidi, N., Ajmal, M. R., Zaidi, S. A. H., & Khan, R. H. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00556 · Cited by 11
Fan, Y., Wang, Z., & He, D. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220817140737 · Cited by 12
“Apart from GLUT1 and GLUT3, the translocation of GLUT4 to the cell membrane was also impaired in the AD brain, despite the fact that the GLUT4 expression level was unchanged in the condition of AD [97, 98].”
Nutrients in Alzheimer’s Disease: The Interaction of Diet, Drugs and Disease
Liyanage, S. I., Vilekar, P., & Weaver, D. F. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2018.353 · Cited by 13
Cognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement
Pickering, J., Wong, R. H. X., Al‐Salami, H., Lam, V., & Takechi, R. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03100-1 · Cited by 12
Peng, Y., Zhang, L., Zhou, F., Wang, Y., Zhang, X., Fan, J., Li, S., Li, X., & Li, Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220610 · Cited by 10
Insulin signaling as a therapeutic target in Alzheimer’s disease: Efficacy of apomorphine
Ohyagi, Y., & Takei, S. (2020) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12369 · Cited by 10
The role of type 2 Diabetes mellitus as a risk factor for Alzheimer's and Parkinson's diseases
Rocha, K. M. A., Goulart, A. D. S., Costa, M. T., Salgueiro, A. C. F., & Folmer, V. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.11673 · Cited by 9
“Induction of DM2 by STZ is a well-documented experimental model (Szablewski, 2017) and, in addition to hyperglycemia, treated animals develop most diabetic complications mediated by oxidative stress, such as neuropathy and diabetic retinopathy (Comelli et al.”
BackgroundZhang, L., Shi, M., Song, C., Cheng, L., Li, X., Yang, Q., Zhang, Y., Dong, R., Kou, J., Lv, C., et al. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104856 · Cited by 9
Obesity-mediated Lipoinflammation Modulates Food Reward Responses
Huerta, C., Caba, M., & Camacho‐Morales, A. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.08.019 · Cited by 9
Rhee, S. J., Min, S., Hong, M., Lee, H., Lee, H., Kang, D. H., & Ahn, Y. M. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111502 · Cited by 9
Shin, B., Cepeda, C., Eghbali, M., Byun, S. Y., Levine, M. S., & Devaskar, S. U. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113603 · Cited by 9
“Introduction Glucose is an essential substrate for brain energy metabolism (Devaskar et al., 1992; Devaskar et al., 1999; Magistretti and Pellerin, 1999), a lack of which causes major neurological deficits (Dworschak et al., 2015; Roeske et al., 2011; Shah et al., 2012; Szablewski, 2017).”
BackgroundNeuronal activity-induced GLUT3 plasma translocation supports energy demands for memory acquisition
Wei, X., Zou, Z.-M., Yao, Z.-X., Teng, S.-W., Wei, X.-Y., Tang, W., Chen, X.-L., He, Y., & Chen, Z.-Y. (2025) · Communications Biology · doi:10.1038/s42003-025-09119-z · Cited by 8
“The levels of GLUT3 and its translocation are decreased in Alzheimer ’ s disease, and glucose hypometabolism and de fi cits in ATP production are observed 9,90 .”
Hahn, A., Falb, P., Murgaš, M., Klug, S., Reed, M. B., Godbersen, G. M., de León, M. P., Milz, C., Hacker, M., Rujescu, D., et al. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261455750 · Cited by 9
Gupta, S., Jinka, S. K. A., Khanal, S., Bhavnani, N., Almashhori, F., Lallo, J., Mathias, A., Al‐Rhayyel, Y., Herman, D. E., Holden, J. G., et al. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25196 · Cited by 8
“Numerous studies support the concept that reduced glucose uptake and hypometabolism in the brain are important contributing factors in ADRD (Chen et al., 2021; Duran- Aniotz & Hetz, 2016; Hunt et al., 2007; Mosconi, 2013; Nicholson et al., 2010; Szablewski, 2017; Zhu et al., 2014).”
BackgroundHexokinase and Glycolysis: Between Brain Cells Life and Death
da Mata, L. R. S., Santos, L., & César, M. C. (2023) · Current Chemical Biology · doi:10.2174/2212796817666230510095530 · Cited by 7
Rezaei, A. A., Hamidi, M., Seyedmirzaei, H., & Moghadasi, A. N. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003124 · Cited by 8
Exploring non-canonical targets in Alzheimer’s disease: a departure from the norm
Jain, S., & Chauhan, N. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00908-7 · Cited by 8
“Specifically, GLUT1 and GLUT3 levels are diminished in the cerebral cortex, while GLUT2 levels increase, presumably as a compensatory mechanism for reduced ATP production [105].”
Li, N., Fang, X., Li, H., Liu, J., Chen, N., Zhao, X., Yang, Q., & Chen, X. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01596-9 · Cited by 6
“ATP production, mediated by glucose metabolism, declines by 50% in AD and continues to decrease over time (Szablewski 2017).”
Likelihood ratio statistics for gene set enrichment in Alzheimer's disease pathways
Bryan, J., Mandan, A., Kamat, G., Gottschalk, W. K., Badea, A., Adams, K. J., Thompson, J. W., Colton, C. A., Mukherjee, S., Lutz, M. W., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12223 · Cited by 6
Glucose transporters and their energy homeostasis function in various organs
Nithya, U., Theijeswini, R. C., Karthick Raja, R., & Gayathri, M. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.08.001 · Cited by 6
Wang, B., Shao, Y., & Liang, R. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin44389 · Cited by 5
Disruption of Glucose Metabolism in Aged Octodon degus: A Sporadic Model of Alzheimer's Disease
Cisternas, P., Gherardelli, C., Salazar, P. L., & Inestrosa, N. C. (2021) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2021.733007 · Cited by 5
“Numerous Gluts are expressed in the brain, including Glut1, which is highly expressed by endothelial cells in the blood-brain barrier and astrocytes; Glut3, the main neuronal transporter; and Glut4, which is present in several brain areas (Ashrafi et al., 2017; Szablewski, 2017).”
BackgroundDysfunctional gene splicing in glucose metabolism may contribute to Alzheimer's disease
Deng, S., Peng, Y., Xu, M., Yi, Q., & Feng, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002214 · Cited by 5
“Glucose metabolism is an essential biochemical process that provides energy for the brain.([56]) Glucose is taken up by the cells using glucose transporters present downstream in the insulin signaling cascade.”
BackgroundGLUT3 expression in cystic change induced by hypoxia in pituitary adenomas
Mei, T., Zhang, J., Wei, L., Xing-feng, Q., Ma, Y., Liu, X., Chen, S., Li, S., Wu, J., & Wang, S. (2018) · Endocrine Connections · doi:10.1530/ec-18-0444 · Cited by 5
Lee, H. C., Carroll, A. J., Crossett, B., Connolly, A. M., Batarseh, A. M., & Djordjevic, M. A. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.595726 · Cited by 6
“In humans, roughly 50% of all known drug targets are TMPs (Hopkins and Groom, 2002; Lappano and Maggiolini, 2011; Tautermann, 2014), and many human diseases are caused by malfunctioning TMPs (Hardy, 2017; Hasegawa et al., 2017; Hattori et al., 2017; Szablewski, 2017).”
BackgroundGifford, E. K., Robbins, E. M., Jaquins‐Gerstl, A., Rerick, M. T., Nwachuku, E. L., Weber, S. G., Boutelle, M. G., Okonkwo, D. O., Puccio, A. M., & Michael, A. C. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00231 · Cited by 5
Altered glucose metabolism and its association with carbonic anhydrase 8 in Machado-Joseph Disease
Lin, G.-Y., Ma, C., Kuo, L.-C., Hsieh, B. Y., Wang, H., Liu, C., & Hsieh, M. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00994-7 · Cited by 5
A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer’s Disease
Mishra, S., Stany, B. K., Das, A., Deepankumar, K., & Vijayan, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04135-2 · Cited by 5
“Meanwhile, SLC1A1/ A2 [61], SLC5A7 [62], and SLC6A [63] transporters are involved in the reuptake of neurotransmitters.”
Sarma, M., & Chatterjee, S. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07237-1 · Cited by 4
“Changes in glucose transporter expression, including GLUT12, can affect brain glucose homeostasis and function, potentially influencing the progression of AD [62] ARHGAP27 Research suggests that ARHGAP27 might play a role in the genetic susceptibility to AD, particularly in late-onset AD (LOAD) [63]”
Nervonic acid and 15-epi-PGA1 mediate systemic mitochondrial dysfunction in AD dementia
Heimler, S., Amick, K. A., Bergstrom, J., Moliné, M., Mahapatra, G., Craft, S., & Molina, A. J. A. (2025) · GeroScience · doi:10.1007/s11357-025-01776-6 · Cited by 4
“In neurons, a wide array of mitochondrial dysfunction can be observed from reduction of cytochrome oxidase activity to abnormal mitochondrial dynamics to impaired glucose metabolism [1, 2, 4].”
Irisin-mediated hepatic autophagy remodels nutritional metabolism to prevent cognitive dysfunction
Zhang, X., Yang, Y., Song, H., Hu, X., Wang, X., & Yu, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102936 · Cited by 4
DHA (omega-3 fatty acid) and estradiol: key roles in regional cerebral glucose uptake
Majou, D., & Dermenghem, A.-L. (2023) · OCL · doi:10.1051/ocl/2023023 · Cited by 4
“GLUT-1 transporters are present on astrocytes and on capillaries (Szablewski, 2017) with two signi fi cant types.”
BackgroundSánchez-Fernández, C., del Olmo‐Aguado, S., Artime, E., Barros, A., Fernández-Vega-Cueto, L., Merayo-Llovés, J., & Alcalde, I. (2024) · Molecules · doi:10.3390/molecules29020456 · Cited by 4
“In this regard, a decrease in the amount of free ATP and GTP are directly related to microtubule instability [48,49] through the participation of the phosphorylation of the tau protein, involving kinases such as CaMKII [50].”
BackgroundKou, J., Lv, C., Cheng, L., Feng, W., Xie, H., Wang, X., Chen, S., Wang, L., Shi, M., Song, X. Y., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106242 · Cited by 4
Deng, M., Wang, Z., Zhao, W., Xu, W., Chen, S., Ma, X., Song, K., & Li, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-27632-3 · Cited by 3
Jans, K., Lüersen, K., von Frieling, J., Roeder, T., & Rimbach, G. H. (2024) · Aging · doi:10.18632/aging.205933 · Cited by 3
“Thus, considering the impact of lithium on glucose metabolism AGING as a potential driver for these findings may be useful [55].”
BackgroundZhao, Y. L., Veysman, B. D., Antolijao, K., Zhao, Y., Papagni, Y., Wang, H., Ross, R., Tibbot, T., Povrzenic, D., & Fox, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158337 · Cited by 3
Cheng, F., Fransson, L., & Mani, K. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70162 · Cited by 3
Whole-Exome sequencing identifies GYS2 biallelic variants in individuals with suspected epilepsy
Ilyas, M., Holzwarth, D., Ishaq, R., Ali, Y., Habiba, U., Raja, A. M., Saeed, S., Abdullah, U., Khan, S. N., Ullah, A., et al. (2023) · Seizure · doi:10.1016/j.seizure.2023.07.020 · Cited by 3
Tian, C., Feng, P.-Y., Wang, L., Liu, T., Li, Y.-X., & Zhao, X. (2026) · PLoS Genetics · doi:10.1371/journal.pgen.1012032 · Cited by 2
“For example, glucose needs to be transported into the brain by sodium-independent glucose transporters (GLUTs), encoded by the solute carrier family 2 (SLC2) genes [14,15].”
The impact of the ketogenic diet on Alzheimer’s disease progression
Grese, Z. R., Naidu, A., Silverglate, B., & Grossberg, G. T. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2026.2621502 · Cited by 2
“A ketogenic diet (KD) that is high in fat and very low in carbohydrates has been proposed as a potential alternative means to fuel the energy-starved AD brain (i.e. a brain with impaired glucose metabolism) [13,14].”
Boustani, A., Laird, A. E., Shu, L., Sundermann, E. E., Moore, D. J., Rissman, R. A., & Fields, J. A. (2026) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2025-0019 · Cited by 2
Ferulic acid inhibits Tau-441 liquid-liquid phase separation to restore glycolytic metabolism
Lin, W.-J., Li, C., Shi, W., Liu, T.-A., Wang, Y.-J., & Li, Y.-J. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151806 · Cited by 2
Mjaaseth, U. N., Hsu, M.-F., Arballo, J., Haj, F. G., & Patel, V. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1710075 · Cited by 2
“SLC2A1 (GLUT1) remained unchanged across disease states, and SLC2A4 (GLUT4) was undetectable, consistent with its limited role in areas outside the hypothalamus and other energy-regulating centers of the brain (Szablewski, 2017).”
Zhang, D., Guo, Z., Yang, Y., & Chang, J. (2022) · Journal of Holistic Integrative Pharmacy · doi:10.1016/s2707-3688(23)00061-4 · Cited by 2
Lu, Y.-S., Tso, K.-C., Hsu, C.-C., Wen, Y.-C., Ohta, J., Yu, T., & Li, S. (2024) · Applied Surface Science · doi:10.1016/j.apsusc.2024.161750 · Cited by 3
Effects of Exercise on Sleep Quality and Dementia-related Factors of Dementia Patients
Yoon, B. K., Kim, J. J., & Kwak, Y. (2019) · JoLS Journal of Life Sciences · doi:10.5352/jls.2019.29.6.740 · Cited by 2
Akimoto, Y., Miura, Y., Endo, T., & Hart, G. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00046-8 · Cited by 2
Kesler, S. R., Cuevas, H. E., Lewis, K., Franco‐Rocha, O. Y., & Flowers, E. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251364906 · Cited by 3
Potential of Benfotiamine in the treatment of neuropsychological disorders
Motamedzadeh, A., Karimzad, Y., Ferdosi, F., Nabavizadeh, F., Rahmati‐Dehkordi, F., Dadgostar, E., Aschner, M., Validad, A., Kazemi, B., & Tamtaji, O. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11198-4 · Cited by 1
“The expression of glucose transporters GLUT1 and GLUT3 is reduced in the brains of patients with Alzheim - er’s disease, contributing to cerebral glucose hypometabolism and subsequent energy deficits [ 14].”
Jain, V., & Bharti, S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.01.011 · Cited by 2
From comorbidity to continuum: Alzheimer’s disease and epilepsy are connected-now what?
Alves, S. S., Manzine, P. R., dos Santos, F. M., Migliaccio, M. M., Alves, L. D. C., da Silva-Júnior, R. M. P., Becerra-Hernández, L. V., González-Acosta, C. A., Buriticá, E., Cominetti, M. R., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106682 · Cited by 1
Mechanisms of transport across the blood–brain barrier
Das, N. G., & Das, S. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00019-2 · Cited by 1
Gupta, M., Rumman, M., Ubaid, S., Mahdi, A. A., & Pandey, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12211-0 · Cited by 1
“Our findings are in line with reported studies which suggest BBR enhanced glucose uptake in T2DM mice [6, 41].”
Mechanisms of neurotoxicity of fluoride or aluminum: implications for neurodegenerative disease risk
Wang, Z.-L., Baker, T. R., & Malin, A. (2026) · Current Research in Toxicology · doi:10.1016/j.crtox.2026.100313 · Cited by 1
“Glucose transporters are critical for supplying neurons and glial cells with the glucose needed for energy production (Szablewski, 2017).”
Lei, Y., Liu, L., & Tang, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103287 · Cited by 1
Nanotechnologies to deliver drugs through the blood–brain and blood–retinal barriers
Costa, M. C., Shegokar, R., Silva, A. M., & Souto, E. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90471-1.00010-4 · Cited by 1
Protective Roles of Melatonin in Alzheimer's Disease: A Review of Experimental and Clinical Research
Davodi-Boroujerd, G., Naghadehi, A. K., Nazari-Serenjeh, F., Alijanpour, S., Ghasemzadeh, Z., & Rastqar, A. (2024) · Jentashapir Journal of Cellular and Molecular Biology · doi:10.5812/jjcmb-139844 · Cited by 1
STARRING ROLE OF MITOCHONDRIAL IMPAIRMENT IN ALZHEIMER’S DISEASE NEUROPATHOLOGY
Yousaf, A., Deeba, F., Younis, S., Iqbal, N., & Aslam, F. (2022) · THE JOURNAL OF MICROBIOLOGY AND MOLECULAR GENETICS · doi:10.52700/jmmg.v3i2.70 · Cited by 1
Supply of Energy Substrate to the Brain
Satoh, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-54150-6_5 · Cited by 1
Effects of Datura stramonium on some key glycolytic enzymes in male albino rats
Owolabi, O. V., Omiyale, B. O., Olukayode, O. J., & Rufina, A. S. Y. (2024) · International Journal of Advanced Biochemistry Research · doi:10.33545/26174693.2024.v8.i7m.1663 · Cited by 1
“Chronic and acute disturbances in glucose availability, usage and storage have been discovered to lead to diseases conditions (Szablewski, 2017) [30] .”
Mouhib, H., Higuchi, A., Abeln, S., Yura, K., & Feenstra, K. A. (2019) · F1000Research · doi:10.12688/f1000research.18553.2
“GLUT3 is also suspected to be associated with neurological disorders such as Alzheimer (An et al., 2018; Gu et al., 2018; Simpson et al., 1994; Szablewski, 2017).”
Frazier, H. N. (2019) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2019.298 · Cited by 1
Estudio de la regulación del metabolismo de la glucosa por la actividad sináptica
Segarra‐Mondejar, M. (2019) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Rebelo, M. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.109.2021.tde-08122021-160246
New therapeutic opportunities for Alzheimer disease
Jang, J. (2022) · Journal of Geriatric Neurology · doi:10.53991/jgn.2021.00017
Ertaş, B., Gun, T., Karakuş, O., KELEŞ, R., Hazar‐Yavuz, A. N., Topal, F., Taşkın, T., & Çam, M. E. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.802
Effects of Metabolic Syndrome on Parkinson’s Disease and Nutraceutical Intervention Strategies
Komuro, J. E., dos Santos, D. F. B., Schelp, A. B., Papini, S. J., & Schelp, A. O. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108956
Metadata
- Authors
- Szablewski, L.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Szablewski, Leszek
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2016-12-20
- Volume
- 55
- Issue
- 4
- Pages
- 1307-1320
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2554650037
- Cited by
- 211
- References
- 161
- Citations by year
- 2026: 18 · 2025: 20 · 2024: 25 · 2023: 20 · 2022: 30 · 2021: 32 · 2020: 35 · 2019: 19 · 2018: 6 · 2017: 6
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- glucose transporters, Alzheimer's disease
- MeSH terms
- Acetylation, Alzheimer Disease, Animals, Brain, Gene Expression Regulation, Humans, Phosphorylation, tau Proteins, N-Acetylglucosaminyltransferases, Glucose Transport Proteins, Facilitative
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.